TARA Protara Therapeutics, Inc.

Fundamentals / CIK 0001359931 / USD

Protara Therapeutics, Inc. reported $156.5M in total assets and a net loss of $78.44M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open TARA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$0$0$0-$61.67MFY 2016 Net Income: -$28.53M2016FY 2017 Net Income: -$29.96M2017FY 2018 Net Income: -$20.73M2018FY 2019 Net Income: -$7.83M2019FY 2020 Net Income: -$33.98M2020FY 2021 Net Income: -$47.25M2021FY 2022 Net Income: -$65.95M2022FY 2023 Net Income: -$40.42M2023FY 2024 Net Income: -$44.60M2024FY 2025 Net Income: -$57.44M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $42.63M $31.70M $24.99M $16.81M $21.09M $11.98M $3.88M $11.85M $21.69M $18.87M
Total Operating Expenses $64.55M $49.15M $43.61M $67.06M $47.49M $34.44M $7.83M $21.37M $30.36M $28.70M
Operating Income -$64.55M -$49.15M -$43.61M -$67.06M -$47.49M -$34.44M -$7.83M -$21.37M -$30.36M -$28.70M
EBITDA -$64.19M -$48.82M -$43.27M -$66.81M -$47.37M -$34.34M -$7.81M -$21.26M -$30.21M -$28.58M
Interest Income $6.38M $4.17M $3.19M $1.11M $237K $500K -- -- -- --
Interest Expense -- -- -- -- $0 $34K -- -- -- --
Income Before Tax $57.35M $44.56M -- -- -- -- -$14.99M -$20.73M -$29.96M -$28.53M
Net Income -$57.44M -$44.60M -$40.42M -$65.95M -$47.25M -$33.98M -$7.83M -$20.73M -$29.96M -$28.53M
Basic EPS -$1.34 -$2.17 -$3.57 -$5.86 -$4.21 -$4.70 -$3.04 -$45.80 -$2.13 -$1.72
Diluted EPS -$1.34 -$2.17 -$3.57 -$5.86 -$4.21 -$4.70 -$3.04 -$45.80 -$2.13 -$1.72
Basic Shares Outstanding 42.8M 20.6M 11.3M 11.3M 11.2M 7.2M 2.6M 452.6K 17.3M 16.6M
Diluted Shares Outstanding 42.8M 20.6M 11.3M 11.3M 11.2M 7.2M 2.6M 452.6K 17.3M 16.6M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $16.80M $16.95M $13.56M $13.12M $9.59M $10.77M $9.15M $9.50M
Total Operating Expenses $23.15M $23.32M $19.63M $19.08M $14.76M $16.59M $14.12M $14.31M
Operating Income -$23.15M -$23.32M -$19.63M -$19.08M -$14.76M -$16.59M -$14.12M -$14.31M
EBITDA -$23.08M -$23.25M -$19.54M -$18.99M -$14.67M -$16.49M -$14.04M -$14.23M
Interest Income $1.47M $1.66M $1.85M $1.52M $1.50M $1.63M $1.73M $1.16M
Net Income -$21.69M -$21.67M -$17.78M -$17.31M -$13.26M -$14.96M -$11.91M -$12.77M
Basic EPS -$0.35 -$0.36 -$0.31 -- -$0.31 -$0.35 -$0.29 --
Diluted EPS -$0.35 -$0.36 -$0.31 -- -$0.31 -$0.35 -$0.29 --
Basic Shares Outstanding 62.9M 61.0M 57.5M -- 42.3M 42.3M 40.7M --
Diluted Shares Outstanding 62.9M 61.0M 57.5M -- 42.3M 42.3M 40.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $49.66M $162.8M $39.59M $24.13M $35.72M $168.6M $564K $19.37M $21.17M $36.39M
Short-Term Investments $105.9M $7.49M $25.99M $60.24M $55.51M -- -- -- -- --
Cash & Short-Term Investments $155.6M $170.3M $65.58M $84.37M $91.23M $168.6M $6.20M $21.90M $42.10M $41.30M
Other Current Assets $65K $2.0K $37K $127K $34K $52K -- -- -- --
Total Current Assets $159.5M $172.2M $68.70M $86.15M $93.11M $169.4M $764K $23.24M $43.48M $42.76M
Property, Plant & Equipment, Net $759K $1.03M $1.30M $1.59M $1.72M $1.24M $459K $263K $259K $372K
Goodwill -- -- -- -- $29.52M $29.52M -- -- -- --
Long-Term Investments $42.34M -- -- $17.89M $39.47M -- -- -- -- --
Other Non-Current Assets $20K $27K $11K $16K $865K $1.16M -- -- $218K $393K
Total Non-Current Assets $49.96M $9.30M $10.25M $27.14M $79.48M $33.72M $459K $285K $499K $765K
Total Assets $209.5M $181.5M $78.95M $113.3M $172.6M $203.2M $1.22M $23.52M $43.98M $43.52M
Accounts Payable $3.47M $4.43M $2.43M $1.59M $954K $914K $716K $441K $291K $556K
Short-Term Debt -- -- -- -- $0 $0 -- -- -- --
Total Current Liabilities $10.94M $10.96M $6.15M $5.74M $4.30M $2.92M $3.35M $3.08M $9.24M $5.08M
Total Non-Current Liabilities $2.12M $3.36M $4.48M $5.47M $6.38M $999K $0 $0 $0 $0
Total Liabilities $13.06M $14.32M $10.63M $11.21M $10.68M $3.91M $3.35M $3.08M $9.24M $5.08M
Total Debt (incl. Leases) $3.36M $4.48M $5.47M $6.38M $7.24M $1.15M -- -- -- --
Common Stock $54K $35K $11K $11K $11K $11K $3.0K $19K $18K $17K
Retained Earnings -$302.4M -$245.0M -$200.4M -$160.0M -$94.01M -$46.76M -$12.78M -$210.5M -$189.7M -$159.8M
Accumulated Other Comp. Income $90K $2.0K -$31K -$688K -$211K -- $3.0K $5.0K -$14K --
Total Stockholders' Equity $196.4M $167.1M $68.32M $102.1M $161.9M $199.2M -$2.13M $4.78M $34.74M $38.44M
Total Equity $196.4M $167.1M $68.32M $102.1M $161.9M $199.2M -$2.13M $4.78M $34.74M $38.44M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $25.15M $17.08M $14.74M $49.66M $12.55M $31.50M $91.46M $162.8M
Short-Term Investments $101.9M $125.4M $121.0M $105.9M $120.1M $90.72M $32.90M $7.49M
Cash & Short-Term Investments $127.0M $142.5M $135.8M $155.6M $132.7M $122.2M $124.4M $170.3M
Other Current Assets $19K $230K $17K $65K $218K $78K $16K $2.0K
Total Current Assets $129.7M $146.2M $140.0M $159.5M $135.6M $125.1M $126.5M $172.2M
Property, Plant & Equipment, Net $1.58M $1.32M $669K $759K $828K $912K $988K $1.03M
Long-Term Investments $16.03M $19.36M $41.64M $42.34M $957K $23.39M $33.15M --
Other Non-Current Assets $60K $74K $76K $20K $21K $29K $35K $27K
Total Non-Current Assets $26.87M $29.94M $51.93M $49.96M $8.99M $31.84M $42.03M $9.30M
Total Assets $156.5M $176.1M $191.9M $209.5M $144.6M $156.9M $168.6M $181.5M
Accounts Payable $4.86M $4.66M $4.03M $3.47M $4.50M $5.30M $2.31M $4.43M
Total Current Liabilities $14.39M $13.32M $8.92M $10.94M $9.91M $9.76M $7.02M $10.96M
Total Non-Current Liabilities $1.13M $1.46M $1.79M $2.12M $2.44M $2.75M $3.06M $3.36M
Total Liabilities $15.52M $14.78M $10.71M $13.06M $12.35M $12.51M $10.07M $14.32M
Total Debt (incl. Leases) $2.44M $2.75M $3.06M $3.36M $3.66M $3.95M $4.23M $4.48M
Common Stock $60K $59K $55K $54K $39K $39K $39K $35K
Retained Earnings -$363.6M -$341.9M -$320.2M -$302.4M -$285.1M -$271.9M -$256.9M -$245.0M
Accumulated Other Comp. Income -$550K -$363K -$364K $90K $143K $77K $89K $2.0K
Total Stockholders' Equity $141.0M $161.3M $181.2M $196.4M $132.3M $144.4M $158.5M $167.1M
Total Equity $141.0M $161.3M $181.2M $196.4M $132.3M $144.4M $158.5M $167.1M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$57.44M -$44.60M -$40.42M -$65.95M -$47.25M -$33.98M -$7.83M -$20.73M -$29.96M -$28.53M
Depreciation & Amortization $362K $332K $341K $248K $117K $103K $16K $115K $148K $123K
Stock-Based Compensation $3.83M $4.12M $6.09M $6.69M $10.36M $9.75M $424K $3.43M $3.23M $3.34M
Change in Payables -$873K $1.38M $848K $631K $40K $198K $366K -- -- --
Operating Cash Flow -$56.37M -$35.81M -$37.56M -$26.46M -$34.50M -$23.41M -$5.01M -$23.23M -$22.35M -$23.69M
Capital Expenditure -$94K -$63K -$45K -$120K -$596K -$884K -$475K -$119K -$35K -$271K
Free Cash Flow -$56.46M -$35.87M -$37.60M -$26.58M -$35.10M -$24.29M -$5.49M -$23.35M -$22.39M -$23.96M
Acquisitions, Net -- -- -- -- -- $3.72M -- -- -- --
Purchases of Investments -$204.6M -$29.38M -$12.19M -$43.55M -$124.7M -- -- -- -- --
Investing Cash Flow -$139.5M $19.16M $53.11M $14.95M -$98.19M $2.83M -$475K $18.43M -$16.10M $19.92M
Common Stock Issued -- -- -- -- -- $73.57M -- -- -- --
Share Repurchases -- -- -$91K -$90K -$228K -- -- -- -- --
Financing Cash Flow $82.72M $139.9M -$91K -$90K -$228K $189.4M $500K $2.98M $23.05M $208K
Net Change in Cash -$113.1M $123.2M $15.46M -$11.60M -$132.9M $168.8M -$13.16M -$1.80M -$15.22M -$3.64M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$21.69M -$21.67M -$17.78M -$17.31M -$13.26M -$14.96M -$11.91M -$12.77M
Depreciation & Amortization $71K $72K $90K $93K $88K $98K $83K $82K
Stock-Based Compensation $1.59M $1.38M $1.36M $1.04M $1.05M $903K $833K $904K
Change in Payables $588K $243K $1.09M -$1.56M -$795K $2.99M -$1.50M $1.52M
Operating Cash Flow -$18.44M -$15.39M -$21.34M -$16.95M -$12.45M -$12.25M -$14.71M -$9.31M
Capital Expenditure -- -- -- -$24K -$4.0K -$22K -$44K --
Free Cash Flow -- -- -- -$16.97M -$12.46M -$12.27M -$14.76M --
Purchases of Investments -$11.78M -$19.23M -$43.86M -$62.71M -$24.41M -$51.70M -$65.81M --
Investing Cash Flow $26.10M $17.75M -$14.72M -$26.91M -$6.51M -$47.72M -$58.35M $22.50M
Financing Cash Flow $412K -$26K $1.14M $80.96M $13K $8.0K $1.73M $97.85M
Net Change in Cash $8.07M $2.34M -$34.92M $37.11M -$18.95M -$59.97M -$71.34M $111.0M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -29.2% -26.7% -59.2% -64.6% -29.2% -17.1% -- -433.8% -86.3% -74.2%
Return on Assets (ROA) -27.4% -24.6% -51.2% -58.2% -27.4% -16.7% -640.2% -88.1% -68.1% -65.5%
Current Ratio 14.58x 15.71x 11.17x 15.01x 21.66x 58.13x 0.23x 7.55x 4.71x 8.42x
Quick Ratio 14.22x 15.54x 10.67x 14.70x 21.23x 57.84x 1.85x 7.12x 4.56x 8.13x
Debt to Equity 0.02x 0.03x 0.08x 0.06x 0.04x 0.01x -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -55.6% -43.4% -34.9% -29.2% -40.0% -35.2% -28.7% -26.7%
Return on Assets (ROA) -50.1% -39.8% -33.0% -27.4% -36.6% -32.4% -26.9% -24.6%
Current Ratio 9.01x 10.97x 15.69x 14.58x 13.69x 12.82x 18.03x 15.71x
Quick Ratio 8.83x 10.70x 15.22x 14.22x 13.39x 12.52x 17.72x 15.54x
Debt to Equity 0.02x 0.02x 0.02x 0.02x 0.03x 0.03x 0.03x 0.03x
Source: SEC EDGAR CompanyFacts (CIK 0001359931) · from December 31, 2012 Data through September 30, 2026 · synced Nov 20, 2026, 05:47 UTC · Open in terminal